Brian T. Powl, Chief Commercial Officer: Fate Therapeutics FATE Sell · Filed 23/07/06

Trade details

Type: Insider sale
Amount: $18,768.98
Shares · price: 3,854 sh · $4.87 a share
Held after: 41,146 sh
Stock: Fate Therapeutics FATE
Person: Brian T. PowlChief Commercial Officer
Trade date: 23/07/05
Filed: 23/07/06
Days to filing: 1 days

Sold 8.6% of holdings

Share of holding sold: 8.6%

Fate Therapeutics trades, last 26 weeks

What else happened in Fate Therapeutics around then

Filed or reported within 30 days of the trade day · 23/06/05~23/08/04

Brian T. Powl's recent trades

Brian T. PowlChief Commercial Officer
SellKura Oncology
Sell
Kura Oncology
KURA
$165.9K
15,430 sh
$165.9K
Filed 09/29
Traded 09/29
Brian T. PowlChief Commercial Officer
SellKura Oncology
Sell
Kura Oncology
KURA
$94.7K
9,020 sh
$94.7K
Filed 09/29
Traded 09/28
Brian T. PowlChief Commercial Officer
SellKura Oncology
Sell
Kura Oncology
KURA
$84.5K
8,000 sh
$84.5K
Filed 09/29
Traded 09/28
Brian T. PowlChief Commercial Officer
Planned sale10b5-1 planKura Oncology
Planned sale10b5-1 plan
Kura Oncology
KURA
$163.7K
15,430 sh
$163.7K
Filed 09/29
Traded 09/29
Brian T. PowlChief Commercial Officer
Planned saleKura Oncology
Planned sale
Kura Oncology
KURA
$97.1K
9,020 sh
$97.1K
Filed 09/28
Traded 09/28